Community Health Worker Asthma Interventions for Children: Results From a Clinically Integrated Randomized Comparative Effectiveness Trial (2016‒2019).

Am J Public Health

Molly A. Martin is with the Department of Pediatrics and the Institute for Health and Research Policy at the University of Illinois at Chicago. Oksana Pugach and Genesis Rosales are with the Institute for Health and Research Policy at the University of Illinois at Chicago. Giselle Mosnaim is with Northshore University Health System, Evanston, IL. Sally Weinstein is with the Department of Psychiatry at the University of Illinois at Chicago. Angkana Roy is with Erie Family Health Center, Chicago. Andrea A. Pappalardo is with the Department of Pediatrics at the University of Illinois at Chicago. Surrey Walton is with the College of Pharmacy at the University of Illinois at Chicago.

Published: July 2021

AI Article Synopsis

  • The Asthma Action at Erie Trial, conducted from 2016 to 2019 in Cook County, focused on improving asthma control in children aged 5-16 by comparing the effectiveness of community health workers (CHWs) and certified asthma educators (AE-Cs).
  • The study included 223 mainly Hispanic, low-income participants and showed significant improvements in asthma control scores for both groups, with the CHW group experiencing notably greater benefits.
  • One year after the interventions ended, the CHW group reported a 42% reduction in days of activity limitation compared to the AE-C group, demonstrating the lasting impact of the CHW intervention even without home environmental remediation tools.

Article Abstract

To compare asthma control for children receiving either community health worker (CHW) or certified asthma educator (AE-C) services. The Asthma Action at Erie Trial is a comparative effectiveness trial that ran from 2016 to 2019 in Cook County, Illinois. Participants (aged 5‒16 years with uncontrolled asthma) were randomized to 10 home visits from clinically integrated asthma CHWs or 2 in-clinic sessions from an AE-C. Participants (n = 223) were mainly Hispanic (85%) and low-income. Both intervention groups showed significant improvement in asthma control scores over time. Asthma control was maintained after interventions ended. The CHW group experienced a greater improvement in asthma control scores. One year after intervention cessation, the CHW group had a 42% reduction in days of activity limitation relative to the AE-C group (b = 0.58; 95% confidence interval = 0.35, 0.96). Both interventions were associated with meaningful improvements in asthma control. Improvements continued for 1 year after intervention cessation and were stronger with the CHW intervention. Clinically integrated asthma CHW and AE-C services that do not provide home environmental remediation equipment may improve and sustain asthma control.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355214PMC
http://dx.doi.org/10.2105/AJPH.2021.306272DOI Listing

Publication Analysis

Top Keywords

asthma control
24
asthma
12
clinically integrated
12
community health
8
health worker
8
comparative effectiveness
8
effectiveness trial
8
ae-c services
8
integrated asthma
8
improvement asthma
8

Similar Publications

IntroductionAsthma attacks are set off by triggers such as pollutants from the environment, respiratory viruses, physical activity and allergens. The aim of this research is to create a machine learning model using data from mobile health technology to predict and appropriately warn a patient to avoid such triggers.MethodsLightweight machine learning models, XGBoost, Random Forest, and LightGBM were trained and tested on cleaned asthma data with a 70-30 train-test split.

View Article and Find Full Text PDF

Background: The relationship between diabetes mellitus (DM) and asthma is complex and can impact disease trajectories.

Aim: To explore the bidirectional influences between the two conditions on clinical outcomes and disease control.

Methods: We systematically reviewed the literature on the relationship between DM and asthma, focusing on their impacts, mechanisms, and therapeutic implications.

View Article and Find Full Text PDF

Explore Alteration of Lung and Gut Microbiota in a Murine Model of OVA-Induced Asthma Treated by CpG Oligodeoxynucleotides.

J Inflamm Res

January 2025

Department of Geriatric Respiratory and Critical Care, The First Affiliated Hospital of Anhui Medical University, Anhui Geriatric Institute, Hefei, Anhui, People's Republic of China.

Aim: We sought to investigate the impact of CpG oligodeoxynucleotides (CpG-ODN) administration on the lung and gut microbiota in asthmatic mice, specifically focusing on changes in composition, diversity, and abundance, and to elucidate the microbial mechanisms underlying the therapeutic effects of CpG-ODN and identify potential beneficial bacteria indicative of its efficacy.

Methods: HE staining were used to analyze inflammation in lung, colon and small intestine tissues. High-throughput sequencing technology targeting 16S rRNA was employed to analyze the composition, diversity, and correlation of microbiome in the lung, colon and small intestine of control, model and CpG-ODN administration groups.

View Article and Find Full Text PDF

Asthma is a common respiratory disease, accounting for 3 to 10 % of severe cases. Among these, bronchiectasis is more frequent (prevalence between 15.5 % and 67.

View Article and Find Full Text PDF

Genome-wide association studies (GWAS) have identified genetic variants robustly associated with asthma. A potential near-term clinical application is to calculate polygenic risk score (PRS) to improve disease risk prediction. The value of PRS, as part of numerous multi-source variables used to define asthma, remains unclear.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!